BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 19059530)

  • 1. Effects of bezafibrate on dyslipidemia with cholestasis in children with familial intrahepatic cholestasis-1 deficiency manifesting progressive familial intrahepatic cholestasis.
    Nagasaka H; Yorifuji T; Hirano K; Ota A; Toyama-Nakagawa Y; Takatani T; Tsukahara H; Kobayashi K; Takayanagi M; Inomata Y; Uemoto S; Miida T
    Metabolism; 2009 Jan; 58(1):48-54. PubMed ID: 19059530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion of high-density lipoprotein and appearance of triglyceride-rich low-density lipoprotein in a Japanese patient with FIC1 deficiency manifesting benign recurrent intrahepatic cholestasis.
    Nagasaka H; Chiba H; Hui SP; Takikawa H; Miida T; Takayanagi M; Yorifuji T; Hasegawa M; Ota A; Hirano K; Kikuchi H; Tsukahara H; Kobayashi K
    J Pediatr Gastroenterol Nutr; 2007 Jul; 45(1):96-105. PubMed ID: 17592371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive familial intrahepatic cholestasis: partial biliary diversion normalizes serum lipids and improves growth in noncirrhotic patients.
    Melter M; Rodeck B; Kardorff R; Hoyer PF; Petersen C; Ballauff A; Brodehl J
    Am J Gastroenterol; 2000 Dec; 95(12):3522-8. PubMed ID: 11151888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of bezafibrate on HDL2/HDL3 ratio in postmenopausal hypertriglyceridemic women.
    Ushiroyama T; Sakuma K; Nosaka S
    J Cardiovasc Pharmacol Ther; 2006 Jun; 11(2):142-8. PubMed ID: 16891292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis.
    Jacquemin E; Hermans D; Myara A; Habes D; Debray D; Hadchouel M; Sokal EM; Bernard O
    Hepatology; 1997 Mar; 25(3):519-23. PubMed ID: 9049190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive familial intrahepatic cholestasis in Malaysian patients--a report of five cases.
    Lee WS; Chai PF; Looi LM
    Med J Malaysia; 2009 Sep; 64(3):216-9. PubMed ID: 20527271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
    Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal pancreatic secretion in children with progressive familial intrahepatic cholestasis type 1.
    Walkowiak J; Jankowska I; Pawlowska J; Bull L; Herzig KH; Socha J
    Scand J Gastroenterol; 2006 Dec; 41(12):1480-3. PubMed ID: 17101580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplantation in children with progressive familial intrahepatic cholestasis.
    Englert C; Grabhorn E; Richter A; Rogiers X; Burdelski M; Ganschow R
    Transplantation; 2007 Nov; 84(10):1361-3. PubMed ID: 18049123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exocrine pancreatic function in children with progressive familial intrahepatic cholestasis type 2.
    Walkowiak J; Jankowska I; Pawlowska J; Strautnieks S; Bull L; Thompson R; Herzig KH; Socha J
    J Pediatr Gastroenterol Nutr; 2006 Apr; 42(4):416-8. PubMed ID: 16641580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive familial intrahepatic cholestasis.
    Cavestro GM; Frulloni L; Cerati E; Ribeiro LA; Corrente V; Sianesi M; Franzè A; Di Mario F
    Acta Biomed; 2002; 73(3-4):53-6. PubMed ID: 12596388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on relationship between expression of familial intrahepatic cholestasis 1 mRNA in placenta and Intrahepatic cholestasis of pregnancy].
    Xu Z; Ke JC; Xing AY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 May; 39(3):430-3. PubMed ID: 18575333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal levels of serum pancreatic enzymes in patients with progressive familial intrahepatic cholestasis type 2.
    Walkowiak J; Jankowska I; Lisowska A; Biczysko M; Wierzbicka A; Pawłowska J
    Acta Biochim Pol; 2010; 57(4):573-5. PubMed ID: 21140002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of living-related liver transplantation for progressive familial intrahepatic cholestasis.
    Cutillo L; Najimi M; Smets F; Janssen M; Reding R; de Ville de Goyet J; Sokal EM
    Pediatr Transplant; 2006 Aug; 10(5):570-4. PubMed ID: 16856993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary prevention with bezafibrate therapy for the treatment of dyslipidemia: an extended follow-up of the BIP trial.
    Goldenberg I; Benderly M; Goldbourt U;
    J Am Coll Cardiol; 2008 Jan; 51(4):459-65. PubMed ID: 18222357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial external biliary diversion in children with progressive familial intrahepatic cholestasis and Alagille disease.
    Yang H; Porte RJ; Verkade HJ; De Langen ZJ; Hulscher JB
    J Pediatr Gastroenterol Nutr; 2009 Aug; 49(2):216-21. PubMed ID: 19561545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allograft steatohepatitis in progressive familial intrahepatic cholestasis type 1 after living donor liver transplantation.
    Miyagawa-Hayashino A; Egawa H; Yorifuji T; Hasegawa M; Haga H; Tsuruyama T; Wen MC; Sumazaki R; Manabe T; Uemoto S
    Liver Transpl; 2009 Jun; 15(6):610-8. PubMed ID: 19479804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
    Sorensen SV; Frick KD; Wade A; Simko R; Burge R
    Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Progressive familial intrahepatic cholestasis presenting as liver failure].
    Sangorrin Iranzo A; Iriondo Sanz M; Alvarez García L; Jara Vega P; Martín de Carpi J
    An Pediatr (Barc); 2009 Dec; 71(6):510-3. PubMed ID: 19811957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The histidine-loop is essential for transport activity of human MDR3. A novel mutation of MDR3 in a patient with progressive familial intrahepatic cholestasis type 3.
    Dzagania T; Engelmann G; Häussinger D; Schmitt L; Flechtenmacher C; Rtskhiladze I; Kubitz R
    Gene; 2012 Sep; 506(1):141-5. PubMed ID: 22766396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.